Articles and resources

Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study)

Pooh, R.K.; Masuda, C.; Matsushika, R.; Machida, M.; Nakamura, T.; Takeda, M.; Ohashi, H.; Kumagai, M.; Uenishi, K.; Roos, F.; Persson, F.; Shimokawa, O. Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study). Diagnostics 2021, 11, 1837. https://doi.org/10.3390/diagnostics11101837
Evaluation of repeat testing of a non-sequencing based NIPT test on a Finnish general-risk population
Prenatal
07 Sep 2021

Evaluation of repeat testing of a non-sequencing based NIPT test on a Finnish general-risk population

Karlsson F, Ahola T, Dahlberg J, Prensky L, Moilanen H, Spalding H. Evaluation of repeat testing of a non- sequencing based NIPT test on a Finnish general- risk population. Acta Obstet Gynecol Scand. 2021;100:1497–1500. https://doi.org/10.1111/aogs.14125
Understanding Fetal Fraction in cfDNA screening
Prenatal
30 Aug 2021

Understanding Fetal Fraction in cfDNA screening

Fetal fraction has been used by some laboratories to determine if they can have confidence in their results. However, there are significant factors to consider when determining its merit, including assay precision, the accuracy of a reported fetal fraction metric and the implications of using a fetal fraction cutoff. In the enclosed publication, we present the science, the data and the impact of using the fetal fraction metric within a clinical context.
Improved outcomes through pre-eclampsia management: Different solutions for different needs
Prenatal
03 Aug 2021

Improved outcomes through pre-eclampsia management: Different solutions for different needs

Professor Jon Hyett, Head of High-Risk Obstetrics and a Senior Staff Specialist in Obstetrics, and Maternal and Fetal Medicine Royal Prince Alfred Hospital, Sydney, Australia
Performance of commercially available placental growth factor tests in women with suspected preterm pre‐eclampsia; the COMPARE study
Prenatal
09 Jun 2021

Performance of commercially available placental growth factor tests in women with suspected preterm pre‐eclampsia; the COMPARE study

F.P. McCarthy et. al. Ultrasound in Obstetrics & Gynecology
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit
Prenatal
09 Jun 2021

Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit

David Wright et. al. The American Journal of Obstetrics & Gynecology
Aspirin versus Placebo in Pregnancies at high Risk for Preterm Preeclampsia
Prenatal
09 Jun 2021

Aspirin versus Placebo in Pregnancies at high Risk for Preterm Preeclampsia

Daniel L. Rolnik et. al. The New England Journal of Medicine
PlGF and assessment of placental function in the first and third trimesters of pregnancy
Prenatal
14 May 2021

PlGF and assessment of placental function in the first and third trimesters of pregnancy

Professor Jon Hyett, Head of High-Risk Obstetrics and a Senior Staff Specialist in Obstetrics, and Maternal and Fetal Medicine Royal Prince Alfred Hospital, Sydney, Australia
First trimester prediction and prevention of pre-eclampsia
Prenatal
24 Apr 2021

First trimester prediction and prevention of pre-eclampsia

Kypros Nicolaides, Professor at King’s College Hospital, London (UK) and founder of Fetal Medicine Foundation (FMF) presents the latest development on predicition and prevention of preterm pre-eclampsia.
Pre-eclampsia Screening Protocol
Prenatal
24 Apr 2021

Pre-eclampsia Screening Protocol